French artificial intelligence (AI) software developer Avicenna.AI has signed a distribution deal with enterprise imaging and digital pathology vendor Sectra.
Under the deal, Avicenna's AI software for neurovascular pathologies will be offered through the Sectra amplifier marketplace, a platform for contracting, purchasing, and servicing of AI applications that have been validated and verified for use at point of care.
Avicenna's software uses deep learning to identify, detect, and quantify pathologies from CT images. The tools automatically detect and prioritize acute intracranial hemorrhage and large vessel occlusion cases within seconds and assess them for severity.
